Indoco Remedies has informed that based on the approval and recommendation of the Nomination & Remuneration Committee and pursuant to the provisions of sections 152, 196, 197, 203 read with Schedule V and all other applicable provisions of the Companies Act, 2013 and all applicable rules made under the Companies Act, 2013, the Board of Directors of the Company has approved the reappointment of Aditi Kare Panandikar as the Managing Director of the Company for a further period of 5 years with effect from February 15, 2017 and Sundeep V. Bambolkar as Jt. Managing Director of the Company for a further period of 5 years with effect from February 15, 2017. The said reappointment is subject to the approval of the Members of the Company and subject to all other concerned statutory, regulatory and other authorities, if and to the extent applicable and required.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: